Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 51 $ 597,982 $ (3,046) $ (334,030) $ 260,957
Balance, shares at Dec. 31, 2022 51,476,445        
Common stock issued in public offering, net of issuance costs [1] $ 8 94,758 94,766
Common stock issued in public offering, net of issuance costs, shares [1] 8,333,333        
Stock-based compensation 7,757 7,757
Stock-based compensation, shares 5,866        
Other comprehensive loss (850) (850)
Net loss (29,801) (29,801)
Common stock issued upon exercises of warrants $ 1 834 835
Common stock issued upon exercise of warrants, shares 557,733        
Balance at Mar. 31, 2023 $ 60 701,331 (3,896) (363,831) 333,664
Balance, shares at Mar. 31, 2023 60,373,377        
Balance at Dec. 31, 2023 $ 93 829,563 (2,536) (537,723) 289,397
Balance, shares at Dec. 31, 2023 92,818,233        
Common stock issued in public offering, net of issuance costs [2] $ 8 25,062 25,070
Common stock issued in public offering, net of issuance costs, shares [2] 8,177,472        
Stock-based compensation 681 681
Stock-based compensation, shares 837        
Other comprehensive loss (1,237) (1,237)
Net loss (17,173) (17,173)
Balance at Mar. 31, 2024 $ 101 $ 855,306 $ (3,773) $ (554,896) $ 296,738
Balance, shares at Mar. 31, 2024 100,996,542        
[1] Includes gross proceeds of $100,000
[2] Includes gross proceeds of $25,651